Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy
Cells · 2024
DOI: 10.3390/cells13050446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Konstantinos Mengrelis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Allergens, Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Lower Austria, State of Lower Austria, Danube Allergy Research Cluster (DARC).
Abstract (Originalsprache)
Up to a third of the world’s population suffers from allergies, yet the effectiveness of available preventative measures remains, at large, poor. Consequently, the development of successful prophylactic strategies for the induction of tolerance against allergens is crucial. In proof-of-concept studies, our laboratory has previously shown that the transfer of autologous hematopoietic stem cells (HSC) or autologous B cells expressing a major grass pollen allergen, Phl p 5, induces robust tolerance in mice. However, eventual clinical translation would require safe allergen expression without the need for retroviral transduction. Therefore, we aimed to chemically couple Phl p 5 to the surface of leukocytes and tested their ability to induce tolerance. Phl p 5 was coupled by two separate techniques, either by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) or by linkage via a lipophilic anchor, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol)-maleimide (DSPE-PEG-Mal). The effectiveness was assessed in fresh and cultured Phl p 5-coupled cells by flow cytometry, image cytometry, and immunofluorescence microscopy. Chemical coupling of Phl p 5 using EDC was robust but was followed by rapid apoptosis. DSPE-PEG-Mal-mediated linkage was also strong, but antigen levels declined due to antigen internalization. Cells coupled with Phl p 5 by either method were transferred into autologous mice. While administration of EDC-coupled splenocytes together with short course immunosuppression initially reduced Phl p 5-specific antibody levels to a moderate degree, both methods did not induce sustained tolerance towards Phl p 5 upon several subcutaneous immunizations with the allergen. Overall, our results demonstrate the successful chemical linkage of an allergen to leukocytes using two separate techniques, eliminating the risks of genetic modifications. More durable surface expression still needs to be achieved for use in prophylactic cell therapy protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Vienna, Austria.
- Institute of Biological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
- Department of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
- Cardiac Surgery Research Laboratory, Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Surgery, Division of Visceral Surgery and Core Facility Flow Cytometry, Medical University of Vienna, 1090 Vienna, Austria.
- Karl Landsteiner University of Health Sciences, 3500 Krems, Austria.
ORCID-Profile: Konstantinos Mengrelis, Verena Kainz, Anna Marianne Weijler, Julia Eckl-Dorna, Ulrike Baranyi, Andreas Spittler, Margarete Focke-Tejkl, Christian Friedrich Wilhelm Becker, Thomas Wekerle
Förderung
- Government of Lower Austria
- State of Lower Austria, Danube Allergy Research Cluster (DARC)
Zitieren
APA
Mengrelis, K., Niederacher, G., Prickler, L., Kainz, V., Weijler, A. M., Rudolph, E., Stanek, V., Eckl-Dorna, J., Baranyi, U., Spittler, A., Focke-Tejkl, M., Bohle, B., Valenta, R., Becker, C. F. W., Wekerle, T., & Linhart, B. (2024). Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy. Cells. https://doi.org/10.3390/cells13050446
Vancouver
Mengrelis K, Niederacher G, Prickler L, Kainz V, Weijler AM, Rudolph E, et al. Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy. Cells. 2024. doi:10.3390/cells13050446
BibTeX
@article{Mengrelis2024,
author = {Mengrelis, Konstantinos and Niederacher, Gerhard and Prickler, Lisa and Kainz, Verena and Weijler, Anna Marianne and Rudolph, Elisa and Stanek, Victoria and Eckl-Dorna, Julia and Baranyi, Ulrike and Spittler, Andreas and Focke-Tejkl, Margarete and Bohle, Barbara and Valenta, Rudolf and Becker, Christian Friedrich Wilhelm and Wekerle, Thomas and Linhart, Birgit},
title = {Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13050446}
}
EUVIMED